Digging into a teased "AI Drug Discovery" pitch from Topline Trader
5 Comments Read MoreArticles
De-tease: “Algo Meds” to Cash in on Kohl’s “No. 1 AI Stock of Our Era”
Women, Statins and Curry
Catching Up on COVID and Keeping Up to Date on Monkeypox
Is “The End of Alzheimer’s” Going to be “Jeff Bezos’ Next Big Thing?”
COVID 19: What Are Prospects for the Duration?
Doc Gumshoe on Arizona, Sweden, Herd Immunity and the Progress of Vaccine Programs
56 Comments Read More58,300% Sales Surge for “Super Vaccine” Company?
What's being touted by Money Morning in ads for Michael Robinson's new Bio-Technology Profit Alliance?
42 Comments Read MoreAnother Look at COVID 19
What’s Teased as “Our #1 Takeover Target for February?”
Today we’ve got a teaser pitch from Dylan Jovine’s new service, Takeover Targets, which he says is “half price” for charter subscribers (that would be $997/year, and unlike many higher-end newsletters they say they do offer refunds for 30 days)… and, as you might imagine, the service is all about identifying companies that might be […]
17 Comments Read MoreCoronavirus Update – February 2020
Combating Cancer: The Current Battle Plan
March 2018 Catch Up: What’s Been Happening in the Pharm World?
The 2017 – 2018 Flu Outbreak: How Bad Is It Really, and What to Do?
Bulletins from the Cardiac Front
Trump’s “Mystery Holding” teased by Oxford Club
"The Shocking Surprise I Found in Trump's Personal Stock Portfolio" -- What's the "secretive, under-the rader company with a stranglehold on a super lucrative niche" hinted at by Chris Matthai?
13 Comments Read MoreMarc Lichtenfeld “Bets His Paycheck” — “GMS” Stock revealed
The Great Gallic Foie Gras Hack
Cancer Care: Where Are We and Where Are We Headed?
[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]
36 Comments Read MoreThe 2015 Stock Gumshoe Biotechnology Awards Show!
Biosimilars: What Are They, and Why On Earth Should We Care?
Oxidation for Health…Physical and Fiscal
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]
1,353 Comments Read MoreA Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?
Hepatitis with a C
Guaranteed Weight Loss without Surgery, Drugs or Dieting! (Really!)
Antibiotics Don’t Get No Respect, But You Can Still Profit From Them
Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
Can you really “Create Extra Paychecks Month After Month Thanks to the ‘MCR Plan?'” (Leeb)
Figuring out the "Income Stacking" picks teased by Stephen Leeb's Complete Investor
5 Comments Read MoreStarting the Year with the Other Experts …
Most of the time I write about the investment newsletter business — the pundits who sell their expertise, the copywriters who make the mundane seem otherworldly, and the outrageous promises and teases that the publishers use to convince us to subscribe to newsletters that proffer investment research and stock tips. But it’s worth noting that […]
6 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
$TSRO $GILD $SNY"Buyout Buzz: Sanofi, Gilead rumors keep the fire burning under a boiling Tesaro buyout story"At...
this was a $2.00 stock at the time of the original post above (9 months ago). WOWFlexion Therapeutics - $FLXN +40% j...
Pre-market actions, 1/6, per IBD at 8:45amIn Motion: Amgen, Regeneron, Ionis, VerizonPremarket action was a mixe...
Sanofi (SNY) and Google teaming up for new start up Onduo targeting diabetes treatments.http://www.xconomy.com/bosto...
Long $RLYP http://tinyurl.com/j5bmn49 Short article, and nice summation of current position. RLYP has applied for Eu...
I think Sanofi ($SNY) was meant....
Sanofi (SNY) on the hunt for rare disease acquisitions.http://finance.yahoo.com/news/100-billion-french-pharma-giant...
Doc KSS,First and foremost, glad you are on the mend.I was wondering if you could kindly comment on the effica...
Could be, the hints were all over the map on this since he's teasing RNAi generally and hinting at lots of studies done ...